474 related articles for article (PubMed ID: 15498503)
21. Gastrointestinal peptide signalling in health and disease.
Rozengurt E; Guha S; Sinnett-Smith J
Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
[TBL] [Abstract][Full Text] [Related]
22. Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
Leyton J; Garcia-Marin LJ; Tapia JA; Jensen RT; Moody TW
Cancer Lett; 2001 Jan; 162(1):87-95. PubMed ID: 11121866
[TBL] [Abstract][Full Text] [Related]
23. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
24. Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line.
Saurin JC; Némoz-Gaillard E; Sordat B; Cuber JC; Coy DH; Abello J; Chayvialle JA
Cancer Res; 1999 Feb; 59(4):962-7. PubMed ID: 10029091
[TBL] [Abstract][Full Text] [Related]
25. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
26. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
Lacoste J; Aprikian AG; Chevalier S
Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
[TBL] [Abstract][Full Text] [Related]
27. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV
Cell Growth Differ; 2000 Jul; 11(7):385-93. PubMed ID: 10939592
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Kiaris H; Schally AV; Sun B; Armatis P; Groot K
Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
[TBL] [Abstract][Full Text] [Related]
29. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
30. [The role of gastrin releasing peptide as a lung growth factor].
Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
[TBL] [Abstract][Full Text] [Related]
31. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
32. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
33. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
[TBL] [Abstract][Full Text] [Related]
34. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
35. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
[TBL] [Abstract][Full Text] [Related]
36. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.
Sharif TR; Luo W; Sharif M
Mol Cell Endocrinol; 1997 Jun; 130(1-2):119-30. PubMed ID: 9220028
[TBL] [Abstract][Full Text] [Related]
37. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells.
DeMichele MA; Davis AL; Hunt JD; Landreneau RJ; Siegfried JM
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):66-74. PubMed ID: 8018339
[TBL] [Abstract][Full Text] [Related]
38. A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.
Oiry C; Pannequin J; Bernad N; Artis AM; Galleyrand JC; Devin C; Cristau M; Fehrentz JA; Martinez J
Eur J Pharmacol; 2000 Sep; 403(1-2):17-25. PubMed ID: 10969139
[TBL] [Abstract][Full Text] [Related]
39. Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
Szepeshazi K; Schally AV; Rick FG; Block NL; Vidaurre I; Halmos G; Szalontay L
Anticancer Drugs; 2012 Oct; 23(9):906-13. PubMed ID: 22926257
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).
Dumesny C; Patel O; Lachal S; Giraud AS; Baldwin GS; Shulkes A
Endocrinology; 2006 Jan; 147(1):502-9. PubMed ID: 16223866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
